EX-10.3


   

  Exhibit 10.3

  REGISTRATION RIGHTS AGREEMENT

  BY AND AMONG

  RANI THERAPEUTICS HOLDINGS, INC.

  AND

  THE “INVESTORS” 
as defined herein,

  Dated as of August 3, 2021

   

   

  

  Table of Contents

   

  Page

   

  				
	1. 
	DEFINITIONS
	1

	2.
	REGISTRATION RIGHTS
	3

	 
	2.1
	Demand Registration.
	3

	 
	2.2
	Shelf Take-Downs
	4

	 
	2.3
	Company Registration
	5

	 
	2.4
	Underwriting Requirements.
	5

	 
	2.5
	Obligations of the Company
	6

	 
	2.6
	Furnish Information
	8

	 
	2.7
	Expenses of Registration
	9

	 
	2.8
	Delay of Registration
	9

	 
	2.9
	Indemnification
	9

	 
	2.10
	Reports Under Exchange Act
	11

	 
	2.11
	Limitations on Subsequent Registration Rights; No Inconsistent Agreement.
	11

	 
	2.12
	“Market Stand‐off” Agreement
	11

	 
	2.13
	Termination of Registration Rights
	12

	3.
	HEDGING TRANSACTIONS
	12

	4.
	MISCELLANEOUS.
	12

	 
	4.1
	Nominees for Beneficial Owners
	12

	 
	4.2
	Amendments and Waivers
	12

	 
	4.3
	Notices
	13

	 
	4.4
	Successors and Assigns
	13

	 
	4.5
	Governing Law; Waiver of Jury Trial
	14

	 
	4.6
	Heading; Interpretations
	14

	 
	4.7
	Severability
	14

	 
	4.8
	Specific Performance
	14

	 
	4.9
	Further Assurances
	14

	 
	4.10
	Additional Investors
	14

	 
	4.11
	Entire Agreement
	14

	 
	4.12
	Delays or Omissions
	14

	 
	4.13
	Counterparts
	15



   

   

   

  			
	 
	i
	 



   

  

   

  REGISTRATION RIGHTS AGREEMENT

  THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of the 3rd day of August, 2021, by and among Rani Therapeutics Holdings, Inc., a Delaware corporation (the “Company”) and each of the Investors listed on Schedule A hereto (together with their successors and Permitted Transferees as provided herein, an “Investor”) and any Person that becomes a party to this Agreement pursuant to Section 4.10 hereto as an “Investor.”

  RECITALS

  WHEREAS, the Investors hold Registrable Securities (as defined herein).

  NOW, THEREFORE, in consideration of the premises and of the mutual covenants and obligations hereinafter set forth, the parties hereto hereby agree as follows:

  1.Definitions.  For purposes of this Agreement:


  1.1“Affiliate” means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by or is under common control with such Person, including without limitation any general partner, managing member, officer or director of such Person or any venture capital or private equity fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management company with, such Person.


  1.2“Agreement” has the meaning specified in the Preamble.


  1.3“Block Sale” means the sale of Equity Securities to one or several purchasers in a registered transaction by means of (i) a bought deal, (ii) a block trade or (iii) a registered direct sale.


  1.4“Class A Common Stock” means the shares of Class A common stock, par value $0.0001 per share, of the Company and any and all securities of any kind whatsoever which may be issued after the date hereof in respect of, or in exchange for, such Class A common stock of the Company pursuant to a merger, consolidation, stock split, stock dividend, conversion or recapitalization of the Company or otherwise.


  1.5“Company” has the meaning specified in the Preamble.


  1.6“Damages” means any loss, damage or liability (joint or several) to which a party hereto may become subject under the Securities Act, the Exchange Act or other federal or state law, insofar as such loss, damage or liability (or any action in respect thereof) arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained in any registration statement of the Company, including any preliminary prospectus, issuer free writing prospectus or final prospectus contained therein or any amendments or supplements thereto; (ii) an omission or alleged omission to state in any registration statement of the Company, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements therein, a material fact required to be stated therein, or necessary to make the statements therein not misleading; or (iii) any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law.


  1.7“Demand Notice” has the meaning specified in Section 2.1(a).


  1.8“Equity Securities” means (i) any and all equity securities of the Company held, directly or indirectly, by the Holders from time to time and (ii) any and all other shares of Class A Common Stock or other equity securities of the Company, securities of the Company convertible into, or exchangeable or exercisable for, such shares and options, warrants or other rights to acquire such shares of Class A Common Stock or other equity securities.


  1

  

   

  1.9“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.


  1.10“Excluded Registration” means (i) a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (ii) a registration relating to an SEC Rule 145 transaction; (iii) a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or (iv) a registration in which either (A) no Class A Common Stock is being registered or (B) the only Class A Common Stock being registered is Class A Common Stock issuable upon conversion of debt securities that are also being registered.


  1.11“Form S‐1” means such form under the Securities Act as in effect on the date hereof or any successor registration form under the Securities Act subsequently adopted by the SEC.


  1.12“Form S‐3” means such form under the Securities Act as in effect on the date hereof or any successor registration form under the Securities Act subsequently adopted by the SEC that permits incorporation of substantial information by reference to other documents filed by the Company with the SEC.


  1.13“Fund Indemnitees” has the meaning specified in Section 2.9(e).


  1.14“Fund Indemnitors” has the meaning specified in Section 2.9(e).


  1.15“Holder” means any other holder of Registrable Securities who is a party to this Agreement.


  1.16“Immediate Family Member” means a child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law, including adoptive relationships, of a natural Person referred to herein.


  1.17“Initiating Holders” means, collectively, Holders who properly initiate a registration request under this Agreement.


  1.18“Investor” has the meaning specified in the Preamble.


  1.19“IPO” means the Company’s first underwritten public offering of its Class A Common Stock pursuant to an effective registration statement under the Securities Act.


  1.20“Permitted Transferee” has the meaning set forth in the Rani LLC Agreement.


  1.21“Person” means any individual, corporation, partnership, trust, limited liability company, association or other entity.


  1.22“Rani LLC” means Rani Therapeutics, LLC, a California limited liability company, and its successors.


  1.23“Rani LLC Agreement” means the Fifth Amended and Restated Limited Liability Company Agreement of Rani LLC, dated as of August 3, 2021, as may be amended, amended and restated, or otherwise modified from to time.


  1.24“Registrable Securities” means (i) any shares of Class A Common Stock held by the Holders at any time; (ii) any shares of Class A Common Stock issued or issuable (directly or indirectly) upon conversion and/or exercise of any other securities of the Company held by the Holders at any time; (iii) any shares of Class A Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares referenced in clauses (i) and (ii) above held by the Holders; or (iv) any shares of Class A Common Stock that may be delivered in exchange for equity interests in Rani LLC pursuant to the terms of the Rani LLC Agreement held by the Holders. As to any 


  2

  

   

  particular Registrable Securities, such securities shall cease to be Registrable Securities when (A) a registration statement with respect to the sale of such securities shall have been declared effective under the Securities Act and such securities shall have been disposed of in accordance with such registration statement, (B) such securities shall have been sold (other than in a privately negotiated sale where the transferor has assigned its rights under this Agreement and the transferee agrees in writing to be bound by the terms hereof) in compliance with the requirements of SEC Rule 144, as such SEC Rule 144 may be amended (or any successor provision thereto) or (C) the registration rights have terminated with respect to such securities pursuant to Section 2.13 of this Agreement.


  1.25“SEC” means the Securities and Exchange Commission.


  1.26“SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act.


  1.27“SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities Act. 


  1.28“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.


  1.29“Shelf Underwritten Offering” has the meaning specified in Section 2.2.


  1.30“Take-Down Notice” has the meaning specified in Section 2.2.


  2.Registration Rights.  The Company covenants and agrees as follows:


  2.1Demand Registration.


  (a)Form S-1 Demand. Subject to Section (c), if the Company receives a request from any Investor at any time after ninety (90) days following the closing of an IPO (so as to effect the registration one hundred eighty (180) days following an IPO, or as soon as reasonably practicable thereafter) that the Company file a Form S-1 registration statement, then the Company shall (i) within ten (10) days after the date such request is given, give notice thereof (the “Demand Notice”) to all Holders other than the Initiating Holders; and (ii) as soon as practicable and within sixty (60) days after the date such request is given by the Initiating Holders but in no event earlier than the earlier of (x) one hundred eighty (180) days following an IPO or (y) the effective date of the underwriters’ waiver of the any of the restrictions set forth in the applicable lock-up agreement entered into in connection with an IPO, file a Form S-1 registration statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be registered and any additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given, and in each case, subject to the limitations of Section 2.4. 


  (b)Form S-3 Demand. Subject to Section (c), if at any time when it is eligible to use a Form S-3 registration statement, the Company receives a request from at least 15% of the Registrable Securities held by Investors that the Company file a Form S-3 registration statement with respect to outstanding Registrable Securities, then the Company shall (x) within ten (10) days after the date such request is given, give a Demand Notice to all Holders other than the Initiating Holders; and (y) as soon as practicable, and in any event within thirty (30) days after the date such request is given by the Initiating Holders, file a Form S-3 registration statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be registered and any additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given, and in each case, subject to the limitations of Section 2.4.  If the Company is a WKSI at the time of any request for Registration in this Section (b), such Form S-3 shall be an automatic shelf registration statement.


  (c)Limitations on Registration. The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Section (a) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be then be eligible to be  registered on Form S-3 pursuant to a request made pursuant to Section (b). The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Section (b) if the Company has effected two (2) registrations pursuant to Section (b) within the twelve (12)-month 


  3

  

   

  period immediately preceding the date of such request. A registration shall not be counted as “effected” for purposes of this Section (c) (i) until such time as the applicable registration statement has been declared effective by the SEC, unless the Initiating Holders withdraw their request for such registration and elect not to pay the registration expenses pursuant to Section 2.7, in which case such withdrawn registration statement shall be counted as “effected” for purposes of this Section (c); provided, however, in the event that a withdrawal by the Holders is based upon material adverse information relating to the Company that is different from the information known or available (upon request from the Company or otherwise) to the Holders requesting registration at the time of their request for registration under this Section 2.1, such registration shall not be treated as “effected” for purposes of this Section 2.1, even though the Holders do not bear the registration expenses for such registration, (ii) if such registration statement is not maintained effective for the period required pursuant to Section 2.5(a) or (iii) if the offering of the Registrable Securities pursuant to such registration statement is subject to a stop order, injunction or similar order or requirement of the SEC during such period, in which case, such requesting holder of Registrable Securities shall be entitled to an additional registration pursuant to Section (a) in lieu thereof.


  (d)At any time before a registration statement covering Registrable Securities becomes effective, the Initiating Holders may request the Company to withdraw or not to file a registration statement. In addition, in the event that a registration statement covering such Registrable Securities is not declared effective within 120 days from the date of first filing with the SEC, the Initiating Holders shall not be deemed to have used one of the registration rights pursuant to Section (c).


  (e)Delay in Filing. If the Company furnishes to the Initiating Holders requesting a registration pursuant to Section (a) or Section (b) a certificate signed by the chief executive officer or the chief financial officer of the Company stating that in the good faith judgment of the Board of Directors of the Company (after consultation with external legal counsel) it would have a material adverse effect on the Company and its stockholders for such registration statement to either become effective or remain effective for as long as such registration statement otherwise would be required to remain effective because such action would (i) materially and adversely interfere with a significant acquisition, corporate reorganization or other similar transaction involving the Company; (ii) require premature disclosure of material, non-public information that the Company has a bona fide business purpose for preserving as confidential and which would be required to be made in, or incorporated into, such registration statement so that such registration statement would not contain any untrue statement of material fact or omit to state a material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading; or (iii) render the Company unable to comply with requirements under the Securities Act or Exchange Act, in each case, the Company shall have the right, upon giving prompt written notice of such action to the Initiating Holders requesting such registration, to delay the filing or initial effectiveness (but not the preparation) of, or suspend use of, such registration statement, and any time periods with respect to filing or effectiveness thereof shall be tolled correspondingly, for a period of not more than forty five (45) days after the request of the Initiating Holders is given; provided that the Company may not invoke this right only once in any twelve (12) month period; provided, further, that the Company shall not deliver a suspension notice pursuant to this Section (e) unless all of the Company’s executive officers and directors are similarly prohibited from effecting any public sales of securities of the Company beneficially owned by them for the duration of such suspension period; and provided, further, that the Company shall not register any securities for its own account or that of any other stockholder during such forty five (45) day period other than pursuant to a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or a registration in which the only Class A Common Stock being registered is Class A Common Stock issuable upon conversion of debt securities that are also being registered. If the Company so delays the filing or the effectiveness of, or suspends the use of, a registration statement, the Initiating Holder shall be entitled, within fifteen (15) days after receipt of such written notice, to withdraw such registration request and, if such registration request is withdrawn, such registration request shall not count for the purposes of the limitations set forth in Section (c).


  2.2Shelf Take-Downs. At any time that a Form S-3 registration statement covering Registrable Securities is effective, subject to Section 2.1(c) and Section 2.1(e), if any of the Investors delivers a notice to the Company (a “Take-Down Notice”) stating that it intends to effect an underwritten offering of all or part of its Registrable Securities included by it on the Form S-3 registration statement (a “Shelf Underwritten Offering”), then 


  4

  

   

  the Company shall amend or supplement the Form S-3 registration statement as may be necessary in order to enable such Registrable Securities to be distributed pursuant to the Shelf Underwritten Offering:


  (a)with respect to any Take-Down Notice that does not pertain to a Block Sale, within two (2) days of receipt of such Take-Down Notice, the Company shall also deliver the Take-Down Notice to all Holders other than the proposing Holder included on such Form S-3 registration statement and permit each Holder to include its Registrable Securities included on the Form S-3 registration statement in the Shelf Underwritten Offering if such Holder notifies the proposing Holder and the Company within five (5) days after delivery (including via e-mail, if available) of the Take-Down Notice to such Holder;


  (b)with respect to any Take-Down Notice pertaining to a Block Sale, within one (1) business day of receipt of such Take-Down Notice, the Company shall also deliver the Take-Down Notice to all Holders other than the proposing Holder included on such Form S-3 registration statement and permit each Holder to include its Registrable Securities included on the Form S-3 registration statement in the Block Sale if such Holder notifies the proposing Holder and the Company within one (1) day after delivery (including via e-mail, if available) of the Take-Down Notice to such Holder; and


  (c)in the event that the underwriter advises such proposing Holder and the Company in its good faith opinion that the total number or dollar amount of Registrable Securities proposed to be sold in such offering is such as to adversely affect the success of such offering (including, without limitation, adversely affect the per share offering price), then the underwriter may limit the number of shares which would otherwise be included in such take-down offering in the same manner as described in Section 2.4(a) with respect to a limitation of shares to be included in a registration.


  2.3Company Registration. If the Company proposes to register (including, for this purpose, a registration effected by the Company for stockholders other than the Holders) any of its Class A Common Stock under the Securities Act in connection with the public offering of such securities solely for cash (other than in an Excluded Registration), the Company shall, at such time, promptly give each Holder notice of such registration. Upon the request of each Holder given within twenty (20) days after such notice is given by the Company, the Company shall, subject to the provisions of Section 2.4, cause to be registered all of the Registrable Securities that each such Holder has requested to be included in such registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2.3 before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration; provided, however, the Company shall not have the right to withdraw the registration of the Registrable Securities unless it is also terminating or withdrawing the registration initiated by it under this Section 2.3 for its own securities. The expenses (excluding underwriting discounts and commissions) of such withdrawn registration shall be borne by the Company in accordance with Section 2.7.


  2.4Underwriting Requirements.


  (a)If, pursuant to Section 2.1, the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to Section 2.1, and the Company shall include such information in the Demand Notice. In the case of a registration pursuant to Section 2.1(a), the underwriter(s) will be selected by a majority-in-interest of the Initiating Holders and shall be reasonably acceptable to the Company. In the case of a registration pursuant to Section 2.3, the underwriter(s) will be selected by the Company and shall be reasonably acceptable to a majority-in-interest of the Holders who have requested to be included in such registration. In such event, the right of any Holder to include such Holder’s Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall (together with the Company as provided in Section 2.5(e)) enter into an underwriting agreement in customary form with the underwriter(s) selected for such underwriting. Notwithstanding any other provision of this Section 2.4, if the managing underwriter(s) advise(s) the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities that otherwise would be underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall 


  5

  

   

  be allocated among such Holders of Registrable Securities, including the Initiating Holders, in proportion (as nearly as practicable) to the number of Registrable Securities owned by each Holder; provided, however, that the number of Registrable Securities held by the Initiating Holders to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest 100 shares.


  (b)In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant to Section 2.3, the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the Holders accept the terms of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity as the underwriters in their sole discretion determine will not jeopardize the success of the offering by the Company. If the total number of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds the number of securities to be sold (other than by the Company) that the underwriters in their reasonable discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the underwriters and the Company in their sole discretion determine will not jeopardize the success of the offering. If the underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable Securities that are included in such offering shall be allocated among the selling Holders in proportion (as nearly as practicable to) the number of Registrable Securities owned by each selling Holder. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest 100 shares. Notwithstanding the foregoing, in no event shall (i) the number of Registrable Securities included in the offering be reduced unless all other securities (other than securities to be sold by the Company) are first entirely excluded from the offering, (ii) the number of Registrable Securities included in the offering be reduced below twenty five percent (25%) of the total number of securities included in such offering, or (iii) notwithstanding (ii) above, any Registrable Securities which are Registrable Securities held by the Investors be excluded from such underwriting unless all other Registrable Securities (other than securities to be sold by the Company) are first excluded from such offering. For purposes of the provision in this Section (b) concerning apportionment, for any selling Holder that is a partnership, limited liability company or corporation, the partners, members, retired partners, retired members, stockholders and Affiliates of such Holder, or the estates and Immediate Family Members of any such partners, retired partners, members and retired members and any trusts for the benefit of any of the foregoing Persons, shall be deemed to be a single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate number of Registrable Securities owned by all Persons included in such “selling Holder,” as defined in this sentence.


  (c)For purposes of Section 2.1, a registration shall not be counted as “effected” if, as a result of an exercise of the underwriter’s cutback provisions in Section (a), fewer than fifty percent (50%) of the total number of Registrable Securities that the Initiating Holders have requested to be included in such registration statement are actually included.


  2.5Obligations of the Company. Whenever required under this Section 2 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible:


  (a)prepare and file with the SEC a registration statement with respect to such Registrable Securities, as expeditiously as reasonably practicable, and use its commercially reasonable efforts to cause such registration statement to become effective and, upon the request of the Initiating Holders, keep such registration statement effective for a period of up to one hundred eighty (180) days or, if earlier, until the distribution contemplated in the registration statement has been completed; provided, however, that (i) such one hundred eighty (180) day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of Class A Common Stock (or other securities) of the Company, from selling any securities included in such registration and (ii) in the case of any registration of Registrable Securities on Form S-3 that are intended to be offered on a continuous or delayed basis, subject to compliance with applicable SEC rules, such one hundred eighty (180) day period shall be extended for up to two (2) years, if necessary, to keep the registration statement effective until all such Registrable Securities are sold; provided, further, that at least five (5) days before filing a registration statement or any amendments or supplements thereto (including documents that would be incorporated or deemed to be incorporated therein by 


  6

  

   

  reference), the Company shall furnish or otherwise make available to the holders of the Registrable Securities covered by such registration statement, their counsel and the managing underwriters, if any, copies of all such documents proposed to be filed, which documents will be subject to the reasonable review and comment of the Investors’ counsel and such other documents reasonably requested by such counsel, including any comment letter from the SEC; provided, further, that the Company shall not file any such registration statement or any amendments or supplements thereto (including such documents that, upon filing, would be incorporated or deemed to be incorporated by reference therein) with respect to a registration pursuant to Section 2.1(a) to which the holders of a majority of the Registrable Securities covered by such registration statement, their counsel, or the managing underwriters, if any, shall reasonably object, in writing, on a timely basis, unless, in the opinion of the Company, such filing is necessary to comply with applicable law; 


  (b)prepare and file with the SEC such amendments and supplements to such registration statement, the prospectus used in connection with such registration statement or any other required document as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such registration statement;


  (c)furnish to the selling Holders, its counsel and each managing underwriter, if any, without charge, such number of copies of a prospectus, including a preliminary prospectus, as required by the Securities Act or as may be reasonably requested, and such other documents as such selling Holders may reasonably request in order to facilitate their disposition of their Registrable Securities;


  (d)use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company shall not be required to qualify to do business or to file a general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act;


  (e)in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the underwriter(s) of such offering, and make such representations and warranties in the underwriting agreement to the holders of such Registrable Securities and the underwriters, if any, with respect to the business of the Company and its subsidiaries, and the registration statement, prospectus and documents, if any, incorporated or deemed to be incorporated by reference therein, in each case, in form, substance and scope as are customarily made by issuers to underwriters in underwritten offerings, and, if true, confirm the same if and when reasonably requested;


  (f)use its commercially reasonable efforts to cause all such Registrable Securities covered by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed;


  (g)use its commercially reasonable efforts to furnish, (i) an opinion, dated as of the date that such Registrable Securities are delivered to the underwriters for sale, if such securities are being sold through underwriters, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and reasonably satisfactory to a majority in interest of the Holders requesting registration of Registrable Securities and (ii) “comfort” letters dated as of the date such Registrable Securities are priced and on the date that such Registrable Securities are delivered to the underwriters for sale, in each case if such securities are being sold through underwriters, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters;


  (h)provide and caused to be maintained a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration;


  7

  

   

  (i)promptly make available for inspection by the selling Holders, any managing underwriter(s) participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders, all financial and other records, pertinent corporate documents and properties of the Company, and cause the Company’s officers, directors, employees and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith;


  (j)use its commercially reasonable efforts to comply with all applicable rules and regulations of the SEC, and make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve months, but not more than eighteen months, beginning with the first month after the effective date of the registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act;


  (k)use its reasonable best efforts to obtain the withdrawal of any order suspending the effectiveness of a registration statement, or the lifting of any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction at the earliest date reasonably practicable;


  (l)use its commercially reasonable efforts to qualify such Registrable Securities for inclusion on the automated quotation system of the National Association of Securities Dealers, Inc., or such other national securities exchange on which any shares of Class A Common Stock are listed or quoted, or, if the Class A Common Stock is not then listed or quoted, use commercially reasonable efforts to list such Registrable Securities on a national securities exchange as the holders of a majority of such Registrable Securities shall reasonably request;


  (m)notify each selling Holder and such selling Holder’s counsel, promptly after the Company receives notice thereof, of the time (i) when such registration statement has been declared effective; (ii) a supplement to any prospectus forming a part of such registration statement has been filed; (iii) of the receipt by the Company of any notification with respect to any comments by the SEC with respect to such registration statement or prospectus or any amendment or supplement thereto or any request by the SEC for the amending or supplementing thereof or for additional information with respect thereto, (iv) of the receipt by the Company of any notification with respect to the issuance by the SEC of any stop order suspending the effectiveness of such registration statement or prospectus or any amendment or supplement thereto or the initiation or threatening of any proceeding for that purpose, and (v) of the receipt by the Company of any notification with respect to the suspension of the qualification of such Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purposes ; or (vi) of the happening of any event that makes any statement made in such registration statement or related prospectus, free writing prospectus, amendment or supplement thereto, or any document incorporated or deemed to be incorporated therein by reference, as then in effect, untrue in any material respect or that requires the making of any changes in such documents so that, in the case of the registration statement, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, not misleading, and that in the case of the prospectus, it will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading (which notice shall notify the selling Holders only of the occurrence of such an event and shall provide no additional information regarding such event to the extent such information would constitute material non-public information);


  (n)after such registration statement becomes effective, notify each selling Holder of any request by the SEC that the Company amend or supplement such registration statement or prospectus; and


  (o)	otherwise use commercially reasonable efforts to take all other steps necessary to effect the registration of such Registrable Securities contemplated hereby.

   

  2.6Furnish Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the 


  8

  

   

  intended method of disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable Securities.


  2.7Expenses of Registration. All expenses (other than underwriting discounts and commissions) incurred in connection with registrations, filings or qualifications pursuant to Section 2, including all registration, filing, qualification, listing and ratings agency fees; printers’ and accounting fees; Securities Act liability insurance if the Company so desires or any underwriters require; and fees and disbursements of counsel for the Company and the Holders who shall have such Registrable Securities effected in registration, shall be borne and paid by the Company, whether or not any registration statement is filed or becomes effective. All underwriting discounts and commissions relating to Registrable Securities registered pursuant to this Section 2 shall be borne and paid by the Holders pro rata on the basis of the number of Registrable Securities registered on their behalf. 


  2.8Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2.


  2.9Indemnification. If any Registrable Securities are included in a registration statement whether or not pursuant to this Section 2:


  (a)To the extent permitted by law, the Company will indemnify and hold harmless each selling Holder, and the partners, members, officers, directors and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the Securities Act) for each such Holder; and each Person, if any, who controls such Holder or underwriter, broker or any other Person acting on behalf of the Holders , against any Damages, and the Company will pay to each such Holder, controlling Person or other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Section (a) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably delayed, conditioned or withheld, nor shall the Company be liable for any Damages to the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of any such Holder, underwriter, controlling Person or other aforementioned Person expressly for use in connection with such registration.


  (b)To the extent permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, and each of its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the Securities Act, legal counsel and accountants for the Company, any underwriter (as defined in the Securities Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other Holder, against any Damages, in each case only to the extent that such Damages arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder expressly for use in connection with such registration; and each such selling Holder will pay to the Company and each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Section (b) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably delayed, conditioned or withheld; provided, further, that in no event shall the aggregate amounts payable by any Holder by way of indemnity or contribution under this Section (b) and Section (d) exceed the proceeds from the offering actually received by such Holder (net of any underwriting discounts and commissions paid by such Holder), except in the case of fraud or willful misconduct by such Holder.


  (c)Promptly after receipt by an indemnified party under this Section 2.9 of notice of the commencement of any action (including any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.9, give the indemnifying party notice of the commencement thereof. The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly with 


  9

  

   

  any other indemnifying party to which notice has been given, and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such action. The failure to give notice to the indemnifying party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of any liability to the indemnified party under this Section 2.9, to the extent that such failure materially prejudices the indemnifying party’s ability to defend such action. The failure to give notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 2.9.


  (d)To provide for just and equitable contribution to joint liability under the Securities Act in any case in which either (i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Section 2.9 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this Section 2.9 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided under this Section 2.9, then, and in each such case, such parties will contribute to the aggregate losses, claims, Damages, liabilities or expenses to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the indemnified party in connection with the statements, omissions or other actions that resulted in such loss, claim, Damage, liability, or expense, as well as to reflect any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission; provided, however, that, in any such case, (x) no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement, and (y) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation; provided, further, that in no event shall a Holder’s liability pursuant to this Section (d), when combined with the amounts paid or payable by such Holder pursuant to Section (b), exceed the proceeds from the offering received by such Holder (net of any underwriting discounts and commissions paid by such Holder), except in the case of willful misconduct or fraud by such Holder.


  (e)The Company hereby acknowledges that certain Holders (the “Fund Indemnitees”) may have rights to indemnification, advancement of expenses and/or insurance with respect to their service on the Board of Directors of the Company or otherwise in connection with their involvement with the Company provided by other Persons (collectively, the “Fund Indemnitors”). The Company hereby agrees (i) that it is the indemnitor of first resort (i.e., its obligations to the Fund Indemnitee are primary and any obligation of the Fund Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities incurred by the Fund Indemnitees are secondary), (ii) that it shall be required to advance the full amount of expenses incurred by the Fund Indemnitees and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement to the extent legally permitted and as required by the terms of this Agreement and the certificate of incorporation or bylaws of the Company (or any other agreement between the Company and the Fund Indemnitees), without regard to any rights the Fund Indemnitees may have against the Fund Indemnitors, and, (iii) that it irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of the Fund Indemnitees with respect to any claim for which the Fund Indemnitees have sought indemnification from the Company shall affect the foregoing and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of the Fund Indemnitees against the Company. The Company and the Fund Indemnitors agree that the Fund Indemnitees are express third party beneficiaries of the terms of this Section (e).


  10

  

   

  (f)The obligations of the Company and Holders under this Section 2.9 shall survive the completion of any offering of Registrable Securities in a registration under this Section 2, and otherwise shall survive the termination of this Agreement.


  2.10Reports Under Exchange Act. With a view to making available to the Holders the benefits of SEC Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S‐3, the Company shall:


  (a)make and keep available adequate current public information, as those terms are understood and defined in SEC Rule 144, at all times after the effective date of the registration statement filed by the Company for the IPO;


  (b)use commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting requirements); and


  (c)furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) to the extent accurate, a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the registration statement filed by the Company for the IPO), the Securities Act, and the Exchange Act (at any time after the Company has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S‐3 (at any time after the Company so qualifies); and (ii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration (at any time after the Company has become subject to the reporting requirements under the Exchange Act) or pursuant to Form S‐3 (at any time after the Company so qualifies to use such form).


  2.11Limitations on Subsequent Registration Rights; No Inconsistent Agreement.


  (a)From and after the date of this Agreement, the Company shall not, without the prior written consent of the Holders of a majority of the Registrable Securities held by all Holders, enter into any agreement with any holder or prospective holder of any securities of the Company that (A) would provide to such holder the right to include securities in any registration on other than either a pro rata basis with respect to the Registrable Securities or on a subordinate basis after all Holders have had the opportunity to include in the registration and offering all shares of Registrable Securities that they wish to so include or (B) allow such holder or prospective holder to initiate a demand for registration of any securities held by such holder or prospective holder; provided that this limitation shall not apply to any additional Investor who becomes a party to this Agreement in accordance with Section 4.10.


  (b)The Company hereby represents that, as of the date hereof, the rights granted to the Holders of Registrable Securities hereunder do not in any way conflict with and are not inconsistent with any other agreements to which the Company is a party or by which it is bound.


  2.12“Market Stand‐off” Agreement. If requested by the Company and an underwriter of Class A Common Stock or any other Equity Securities of the Company, each Holder shall not, without the prior written consent of the managing underwriter(s), during the period commencing on the date of the final prospectus relating to the registration by the Company of shares of its Class A Common Stock or any other Equity Securities under the Securities Act on a registration statement on Form S-1 or Form S-3, and ending on the date specified by the Company and the managing underwriter (such period not to exceed ninety (90) days or such other period as may be requested by the Company or an underwriter), (i) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any shares of Class A Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Class A Common Stock held immediately before the effective date of the registration statement for such offering or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Class A Common Stock or other securities, in cash, or otherwise; provided that all executive officers and directors of the Company are bound by and have entered into 


  11

  

   

  similar agreements unless waived by the Holders, which waiver shall be in the sole discretion of the Holders. The foregoing provisions of this Section 2.12 shall not apply to (i) the registration and sale of any Registrable Securities on a registration statement on Form S-1 or Form S-3 or (ii) the sale of any shares by the Holders to an underwriter pursuant to an underwriting agreement (including any Registrable Securities), or the transfer of any shares to any trust for the direct or indirect benefit of the Holder or an Immediate Family Member of the Holder, provided that the trustee of the trust agrees to be bound in writing by the restrictions set forth herein, and provided, further, that any such transfer shall not involve a disposition for value. The underwriters in connection with such registration are intended third‐party beneficiaries of this Section 2.12 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. If requested by the Company and an underwriter of Class A Common Stock (or other securities) of the Company, each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration that are consistent with this Section 2.12 or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to all Holders subject to such agreements, based on the number of shares subject to such agreements.


  2.13Termination of Registration Rights. The right of any Holder to request inclusion of Registrable Securities in any registration pursuant to Section 2.1 shall terminate and be of no further force or effect at such time after the IPO that such Holder holds less than 1% of the Company’s then outstanding Class A Common Stock (treating for this purpose all shares of Class A Common Stock issuable upon exercise of or conversion of outstanding options, warrants or convertible securities, as if exercised or convertedf); provided, that such Holder’s rights and obligations pursuant to Section 2.9, as well as the Company’s obligations to pay expenses pursuant to Section 2.7, shall survive with respect to any registration statement in which any Registrable Securities of such Holder were included and, for the avoidance of doubt, any underwriter lock-up pursuant to Section 2.12 that a Holder has executed prior to a Holder’s termination in accordance with this clause shall remain in effect in accordance with its terms.


  3.Hedging Transactions. The parties agree that the provisions of this Agreement relating to the registration, offer and sale of Registrable Securities apply also to (i) any transaction which transfers some or all of the economic risk of ownership of Registrable Securities, including any forward contract, equity swap, put or call, put or call equivalent position, collar, margin loan, sale of exchangeable security or similar transaction (including the registration, offer and sale under the Securities Act of Registrable Securities pledged to the counterparty to such transaction or of securities of the same class as the underlying Registrable Securities by the counterparty to such transaction in connection therewith), and that the counterparty to such transaction shall be selected in the sole discretion of the Holders and (ii) any derivative transactions in which a broker-dealer, other financial institution or unaffiliated Person may sell Registrable Securities covered by any prospectus and the applicable prospectus supplement including short sale transactions using Registrable Securities pledged by a Holder or borrowed from the Holder or others and Registrable Securities loaned, pledged or hypothecated to any such party. The prospectus shall permit, in connection with derivative transactions, a broker-dealer, other financial institution or third party to sell shares of the Registrable Securities covered by such prospectus and the applicable prospectus supplement, including in short sale transactions.


  4.Miscellaneous.


  4.1Nominees for Beneficial Owners. If Registrable Securities are held by a nominee for the beneficial owner thereof, the beneficial owner thereof may, at its option, be treated as the Holder of such Registrable Securities for purposes of any request or other action by any Holder or Holders of Registrable Securities pursuant to this Agreement, provided that the Company shall have received assurances reasonably satisfactory to it of such beneficial ownership, written confirmation from such nominee and the beneficial owner agrees to be bound by the terms of this Agreement, including Section 2.12.


  4.2Amendments and Waivers. Except as otherwise provided herein, no modification, amendment or waiver of any provision of this Agreement shall be effective against the Company or any Holder unless such modification, amendment or waiver is approved in writing by the Company and the Holders of a majority of the Registrable Securities then outstanding. No waiver of any of the provisions of this Agreement shall be deemed to or shall constitute a waiver of any other provision hereof (whether or not similar). No failure or delay on the part of any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof or of any other or future exercise of any such right, power or privilege.


  12

  

   

  4.3Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or: (i) personal delivery to the party to be notified; (ii) when sent, if sent by e-mail during the recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one (1) business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery, with written verification of receipt. All communications shall be sent to the Investors at their addresses as set forth on Schedule A hereto, or to the principal office of the Company and to the attention of the Chief Financial Officer, in the case of the Company, or to such facsimile number or address as subsequently modified by written notice given in accordance with this Section 4.3. If notice is given to the Company or to the Investors, a copy shall be sent to such party at the addresses set forth below: 


  if to the Company, to:

Rani Therapeutics Holdings, Inc.
2051 Ringwood Avenue
San Jose, CA 95131
Attention: Chief Financial Officer
Email: svai@ranitherapeutics.com

  with a copy (which shall not constitute notice) to

Cooley LLP
3175 Hanover Street
Palo Alto, CA  94304-1130
Attention: Josh Seidenfeld
Email: jseidenfeld@cooley.com

  if to the Investors, to: 

[c/o 
[Address]
Attention: 
Email: ]

  with a copy (which shall not constitute notice) to

Wilson Sonsini Goodrich & Rosati, P.C.
650 Page Mill Road
Palo Alto, CA  94304
Attention: Adam Bloom
Email: abloom@wsgr.com

  4.4Successors and Assigns. The rights under this Agreement may be assigned (but only with all related obligations) by a Holder to a transferee of Registrable Securities in accordance with the Company’s organizational documents and the Rani LLC Agreement provided, however, that (A) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee and the Registrable Securities with respect to which such rights are being transferred; and (B) such transferee agrees in a written instrument delivered to the Company to be bound by and subject to the terms and conditions of this Agreement, including the provisions of Section 2.11. For the purposes of determining the number of shares of Registrable Securities held by a transferee, the holdings of a transferee (i) that is an Affiliate or stockholder of a Holder; (ii) who is a Holder’s Immediate Family Member; or (iii) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family Member shall be aggregated together and with those of the transferring Holder; provided, further, that all transferees who would not qualify individually for assignment of rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices, or taking any action under this Agreement. The terms and 


  13

  

   

  conditions of this Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided herein. If any Holder shall acquire additional Registrable Securities, such Registrable Securities shall be subject to all of the terms, and entitled to all the benefits, of this Agreement.


  4.5Governing Law; Waiver of Jury Trial. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. Any dispute relating hereto shall be heard in the state or federal courts of Delaware, and the parties agree to exclusive jurisdiction and venue therein and waive any objection based on venue or forum non conveniens with respect to any action instituted therein. TO THE EXTENT ALLOWABLE UNDER APPLICABLE LAW, THE PARTIES HERETO HEREBY IRREVOCABLY WAIVE ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.


  4.6Heading; Interpretations. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. All Section references are to this Agreement unless otherwise expressly provided. When used in this Agreement, the words “include,” “includes” and “including” are to be read as if they were followed by the phrase “without limitation.”


  4.7Severability. Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of the terms or provisions of this Agreement in any other jurisdiction.


  4.8Specific Performance. The parties hereto acknowledge that there would be no adequate remedy at law if any party fails to perform any of its obligations hereunder, and accordingly agree that each party, in addition to any other remedy to which it may be entitled at law or in equity, shall be entitled to injunctive relief, including specific performance, to enforce such obligations without the posting of any bond, and, if any action should be brought in equity to enforce any of the provisions of this Agreement, none of the parties hereto shall raise the defense that there is an adequate remedy at law. All remedies, either under this Agreement, by law, or otherwise afforded to any party, shall be cumulative and not alternative.


  4.9Further Assurances. Each party hereto shall do and perform or cause to be done and performed all such further acts and things and shall execute and deliver all such other agreements, certificates, instruments and documents as any other party hereto reasonably may request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.


  4.10Additional Investors. Notwithstanding anything to the contrary contained herein, if the Company issues to any Person additional Class A Common Stock or equity interests convertible into or exercisable for shares of Class A Common Stock, such Person may become an “Investor” pursuant to this Agreement with the prior written consent of the Investors holding a majority of the Registrable Securities held by all Investors by (i) executing and delivering an additional counterpart signature page to this Agreement, and (ii) agreeing in writing to be bound by all of the obligations of an “Investor” hereunder. Thereafter, each additional Investor shall be deemed an “Investor” for all purposes hereunder. 


  4.11Entire Agreement. This Agreement (including any Schedules hereto) constitutes the full and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled. 


  4.12Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party, nor shall it be construed to be a waiver of or acquiescence to any such breach or default, or to any similar breach or default thereafter occurring, nor shall any 


  14

  

   

  waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All remedies, whether under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.


  4.13Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one instrument. For purposes of this Agreement, a document (or signature page thereto) signed and transmitted by facsimile machine or other electronic means (including pdf) is to be treated as an original document. The signature of any party on any such document, for purposes hereof, is to be considered as an original signature, and the document transmitted is to be considered to have the same binding effect as an original signature on an original document. At the request of any party, any facsimile or other electronic signature is to be re-executed in original form by the party which executed the facsimile or other electronic signature. No party may raise the use of a facsimile machine or other electronic means, or the fact that any signature was transmitted through the use of a facsimile machine or other electronic means, as a defense to the enforcement of this Agreement.


  [Remainder of Page Intentionally Left Blank]

   

  15

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	 
	 

	COMPANY:

	 
	 

	RANI THERAPEUTICS HOLDINGS, INC.

	 
	 

	 
	 

	By:
	/s/ Talat Imran

	 
	Name: Talat Imran

	 
	Title: Chief Executive Officer



   

   

   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  		
	INVESTOR:

	 

	ALPHA SUGARCOAT INVESTMENT LLC

	 
	 

	 
	 

	By:
	/s/ Renee Li

	 
	Name: Renee Li

	 
	Title: Chief Executive Officer



   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  		
	INVESTOR:

	 

	BUTTONWOOD ALPHA QP FUND LLC – SERIES RANI IV

	 
	 

	 
	 

	By:
	/s/ Stephan A. Stein

	 
	Name: Stephan A. Stein

	 
	Title: Member

	 
	 

	BUTTONWOOD ALPHA QP FUND LLC – SERIES RANI III

	 
	 

	 
	 

	By:
	/s/ Stephan A. Stein

	 
	Name: Stephan A. Stein

	 
	Title: Member

	 
	 

	BUTTONWOOD ALPHA FUND LLC

	 
	 

	By:
	Buttonwood Select Opportunities Management Associates LLC, its Manager

	 
	 

	By:
	/s/ Stephan A. Stein

	 
	Name: Stephan A. Stein

	 
	Title: Manager

	 
	 

	BUTTONWOOD ALPHA QP FUND LLC

	 
	 

	By:
	Buttonwood Select Opportunities Management Associates LLC, its Manager

	 
	 

	By:
	/s/ Stephan A. Stein

	 
	Name: Stephan A. Stein

	 
	Title: Manager



   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  	 

  		
	INVESTOR:

	 

	ER INVESTMENT GROUP 1 LLC

	 
	 

	 
	 

	 
	 

	By:
	/s/ Elie Rieder

	 
	Name: Elie Rieder

	 
	Title: Managing Member

	 
	 

	ERS INVESTMENTS LLC

	 
	 

	 
	 

	 
	 

	By:
	/s/ Elie Rieder

	 
	Name: Elie Rieder

	 
	Title: Managing Member

	 
	 



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  		
	INVESTOR:

	 

	GV 2013, L.P.

	 
	 

	By:
	GV 2013 GP, L.L.C.,

	Its:
	General Partner

	 
	 

	 
	 

	By:
	/s/ Inga Goldbard

	 
	Name: Inga Goldbard

	 
	Title: General Counsel

	 
	 

	GV 2015, L.P.

	 
	 

	By:
	GV 2015 GP, L.L.C.

	Its:
	General Partner

	 
	 

	 
	 

	By:
	/s/ Inga Goldbard

	 
	Name: Inga Goldbard

	 
	Title: General Counsel

	 
	 

	GV 2017, L.P.

	 
	 

	By:
	GV 2017 GP, L.P., its General Partner

	By:
	GV 2017 GP, L.L.C., its General Partner

	 
	 

	 
	 

	By:
	/s/ Inga Goldbard

	 
	Name: Inga Goldbard

	 
	Title: General Counsel

	 
	 



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  		
	INVESTOR:

	 

	INCUBE LABS, LLC

	 
	 

	 
	 

	 
	 

	By:
	/s/ Mir Imran

	 
	Name: Mir Imran

	 
	Title: President

	 
	 



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  		
	INVESTOR:

	 

	INCUBE VENTURES II, L.P.

	 
	 

	 
	 

	 
	 

	By:
	/s/ Andrew Farquharson

	 
	Name: Andrew Farquharson

	 
	Title: Managing Member

	 
	 



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  		
	INVESTOR:

	 

	MEDIMMUNE, LLC

	 
	 

	 
	 

	 
	 

	By:
	/s/ David E. White

	 
	Name: David E. White

	 
	Title: Treasurer

	 
	 



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  	 

  		
	INVESTOR:

	 

	NOVARTIS PHARMACEUTICALS CORPORATION

	 
	 

	 
	 

	By:
	/s/ Marc Ceulemans

	 
	Name: Marc Ceulemans

	 
	Title: Head of Strategic Venture Fund & Pharma Equities



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  		
	INVESTOR:

	 

	RANI INVESTMENT CORP.

	 
	 

	 
	 

	By:
	/s/ Andrew Farquharson

	 
	Name: Andrew Farquharson

	 
	Title: Managing Director



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  		
	INVESTOR:

	 

	TAKEDA VENTURES, INC.

	 
	 

	 
	 

	By:
	/s/ Michael Martin

	 
	Name: Michael Martin

	 
	Title: President, Takeda Ventures, Inc.



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  	
	INVESTOR:

	 

	Andrew Farquharson

	 

	 

	/s/ Andrew Farquharson

	(Signature)

	 



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  	
	INVESTOR:

	 

	Talat Imran

	 

	 

	/s/ Talat Imran

	(Signature)

	 



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  		
	INVESTOR:

	 

	DAVID PYOTT LIVING TRUST

	 
	 

	 
	 

	By:
	/s/ David Pyott

	 
	Name: David Pyott

	 
	Title: Trustee



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  	 

  	 

  	
	INVESTOR:

	 

	David Pyott

	 

	 

	/s/ David Pyott

	(Signature)

	 



   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

   

  	
	INVESTOR:

	 

	Angela Murch

	 

	 

	/s/ Angela Murch

	(Signature)

	 



   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	INVESTOR:

	 
	 

	Dennis Ausiello

	 
	 

	By:
	/s/ Dennis Ausiello



   

   

   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	INVESTOR:

	 
	 

	Arvinder Dhalla

	 
	 

	By:
	/s/ Arvinder Dhalla



   

   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	INVESTOR:

	 
	 

	Mir Hashim

	 
	 

	By:
	/s/ Mir Hashim



   

   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	INVESTOR:

	 
	 

	Stephanie McGrory

	 
	 

	By:
	/s/ Stephanie McGrory



   

   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	INVESTOR:

	 
	 

	Maulik Nanavaty

	 
	 

	By:
	/s/ Maulik Nanavaty



   

   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	INVESTOR:

	 
	 

	Christine Phan

	 
	 

	By:
	/s/ Christine Phan



   

   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	INVESTOR:

	 
	 

	Svai Sanford

	 
	 

	By:
	/s/ Svai Sanford



   

   

   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	INVESTOR:

	 
	 

	Mohsen Shirazi

	 
	 

	By:
	/s/ Mohsen Shirzai



   

   

   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	INVESTOR:

	 
	 

	Betsy Gutierrez

	 
	 

	By:
	/s/ Betsy Gutierrez



   

   

   

  Signature Page to Registration Rights Agreement

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  		
	INVESTOR:

	 
	 

	Gary Dang

	 
	 

	By:
	/s/ Gary Dang



   

   

   

   

  Signature Page to Registration Rights Agreement

  

   

  SCHEDULE A

  Investors

  [...]

   

   

   

  

   

  JOINDER TO

  REGISTRATION RIGHTS AGREEMENT

March 18, 2022

   

  Reference is made to that certain Registration Rights Agreement (as may be further amended and/or restated from time to time, the “Registration Rights Agreement”), dated as of August 3, 2021, by and among Rani Therapeutics Holding, Inc., a Delaware corporation (the “Company”), and each investor listed on Schedule A of the Registration Rights Agreement together with their successors and Permitted Transferees as provided for in the Registration Rights Agreement (each, an “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Registration Rights Agreement.

  The undersigned hereby acknowledges and agrees that its signature below constitutes an executed counterpart to the Registration Rights Agreement and hereby agrees to, and does become a party to, the Registration Rights Agreement as an Investor thereunder. 

  Notwithstanding the foregoing, the undersigned further agrees to be bound by, and to comply with, all provisions contained in the Registration Rights Agreement as an Investor. This Joinder shall serve as a counterpart signature page to the Registration Rights Agreement and by executing below the undersigned is deemed to have executed the Registration Rights Agreement with the same force and effect as if originally named a party thereto.

  The undersigned hereby acknowledges that it has received a copy of the Registration Rights Agreement. For purposes of notices under the Registration Rights Agreement, the address of the undersigned Investor is set forth on its signature page below.

  [Remainder of Page Intentionally Left Blank.]

    

   

  

   

  Accordingly, the undersigned have duly executed this joinder as of the date first set forth above.

  	
	INVESTOR

	 

	AEQUANIMITAS LIMITED PARTNERSHIP

	By its general partner Aequanimitas Management LLC

	 

	/s/ Isidoro Quiroga Cortés

	By: Isidoro Quiroga Cortés

	Title: Manager

	 

	 

	Address:



   

   

   

   

   

   

   

   

   

   

  

   

  Accordingly, the undersigned have duly executed this joinder as of the date first set forth above.

  		
	INVESTOR:

	 

	SOUTH LAKE ONE LLC

	 

	 

	 
	/s/ Isidoro Quiroga Moreno

	By:
	 Isidoro Quiroga Moreno

	Title:
	President

	 
	 

	 
	 

	 
	 

	 
	/s/ Luis Felipe Correa González

	By:
	Luis Felipe Correa González

	Title:
	President

	 
	 

	Address:
	 



   

   

   

   

   

   

   

   

  

   

   

   

  Agreed and Accepted by the Company:

   

  				
	RANI THERAPEUTICS HOLDINGS, INC.

	 

	 

	By: 
	 
	/s/ Talat Imran

	 
	 
	Name:
	Talat Imran

	 
	 
	Title:
	Chief Executive Officer